6657 fundamentals
An in-depth look to ENERGENESIS BIOMEDICAL CO LTD operating, investing, and financing activities
6657 free cash flow for Q3 24 is -77.14 M TWD. For 2023, 6657 free cash flow was -225.89 M TWD and operating cash flow was -225.05 M TWD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM